9 Meters Biopharma Inc reports results for the quarter ended in December - Earnings Summary

9 Meters Biopharma

28/03/2023 15:03

* 9 Meters Biopharma Inc  NMTR.OQ  reported a quarterly
adjusted
loss of 92 cents​​ per share for the quarter ended in December.
The mean expectation of six analysts for the quarter was for a
loss of 76 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * 9 Meters Biopharma Inc's reported EPS for the quarter was
a loss
of 92 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * 9 Meters Biopharma Inc shares had risen by 6.3% this
quarter.
    * The company reported a quarterly loss of $11.93 million.
    * Wall Street's median 12-month price target for 9 Meters
Biopharma Inc is $39.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 02:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.76          -0.92          Missed
 Sep. 30 2022      -0.82          -0.72          Beat
 Jun. 30 2022      -0.83          -0.80          Beat
 Mar. 31 2022      -0.75          -0.80          Missed